论文部分内容阅读
目的 了解前列腺素E1 (PGE1 )对慢性肾功能不全患者的治疗作用。方法 将 46例病人随机分为治疗组 2 8例 ,对照组 18例 ,治疗组用PGE1 2 0 0 μg加入 5 %葡萄糖注射液或生理盐水 5 0 0ml中缓慢静脉滴注 ,每日 1次 ,2 1d为 1疗程 ;对照组口服特拉唑嗪 2mg ,每晚 1次。通过监测两组治疗前后血压、尿蛋白、血肌酐及血尿素氮的变化判断PGE1 的治疗效果。结果 两组治疗后上述各项指标均有显著下降 ,其中治疗组尿蛋白下降较对照组显著 (P <0 .0 5 )。结论 PGE1 可以显著降低慢性肾功能不全患者的血压、尿蛋白、血肌酐及血尿素氮
Objective To investigate the therapeutic effect of prostaglandin E1 (PGE1) on patients with chronic renal failure. Methods 46 patients were randomly divided into treatment group 28 cases, control group 18 cases, the treatment group with PGE1 200 μg 5% glucose injection or saline 500 ml slow intravenous infusion, once daily, 2 1d for a course of treatment; control group oral terazosin 2mg, 1 night. By monitoring the two groups before and after treatment, blood pressure, urinary protein, serum creatinine and blood urea nitrogen changes to determine the therapeutic effect of PGE1. Results After treatment, the above indexes were significantly decreased in both groups, of which the proteinuria in treatment group was significantly lower than that in control group (P <0.05). Conclusion PGE1 can significantly reduce the blood pressure, urine protein, serum creatinine and blood urea nitrogen in patients with chronic renal insufficiency